Marjolein Drent Selected Research

Sarcoidosis (Schaumann Disease)

12/2022	Comorbidities of sarcoidosis.
10/2020	The Burden of Neurosarcoidosis: Essential Approaches to Early Diagnosis and Treatment.
8/2020	Benefit of Wearing an Activity Tracker in Sarcoidosis.
1/2020	Methotrexate in sarcoidosis: hematologic and hepatic toxicity encountered in a large cohort over a six year period.
1/2020	Income and Other Contributors to Poor Outcomes in U.S. Patients with Sarcoidosis.
1/2020	Infection prevention in sarcoidosis: proposal for vaccination and prophylactic therapy.
1/2020	Risk and outcome of COVID-19 infection in sarcoidosis patients: results of a self-reporting questionnaire.
1/2019	Sarcoidosis in a patient clinically diagnosed with silicosis; is silica associated sarcoidosis a new phenotype?
1/2018	Nutrition and corticosteroids in the treatment of sarcoidosis.
11/2017	The necessity of external validation in exhaled breath research: a case study of sarcoidosis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marjolein Drent Research Topics

Disease

47	Sarcoidosis (Schaumann Disease) 12/2022 - 06/2002
10	Interstitial Lung Diseases (Interstitial Lung Disease) 11/2021 - 04/2003
8	Pulmonary Sarcoidosis 03/2020 - 07/2005
7	Fatigue 08/2020 - 06/2004
6	Inflammation (Inflammations) 01/2020 - 09/2003
5	Lung Diseases (Lung Disease) 12/2022 - 09/2004
5	Granuloma 01/2020 - 09/2003
4	Necrosis 03/2020 - 03/2006
4	Hemorrhage 01/2019 - 02/2010
4	Drug-Related Side Effects and Adverse Reactions 01/2019 - 09/2007
4	Ventilator-Associated Pneumonia 01/2011 - 07/2004
3	Idiopathic Pulmonary Fibrosis 11/2021 - 01/2018
3	Neurosarcoidosis 01/2020 - 07/2004
2	Neoplasms (Cancer) 12/2022 - 09/2012
2	Infections 01/2020 - 01/2020
2	Chronic Disease (Chronic Diseases) 01/2019 - 01/2018
2	Genetic Predisposition to Disease (Genetic Predisposition) 01/2019 - 07/2005
2	Pulmonary Alveolar Proteinosis 03/2016 - 12/2015
2	Small Fiber Neuropathy 03/2006 - 06/2005
2	Pneumonia (Pneumonitis) 08/2005 - 04/2003
1	Acidosis 11/2021
1	COVID-19 01/2020
1	Gastroesophageal Reflux (GERD) 01/2020
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 03/2019
1	Silicosis 01/2019
1	Disease Progression 01/2019
1	Fibrosis (Cirrhosis) 01/2018
1	Emphysema 01/2018
1	Asthma (Bronchial Asthma) 01/2018
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2018
1	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 08/2015
1	Pulmonary Eosinophilia (Eosinophilic Pneumonia) 07/2015
1	Rheumatoid Arthritis 06/2014

Drug/Important Bio-Agent (IBA)

9	Pharmaceutical PreparationsIBA 12/2022 - 04/2003
9	Infliximab (Remicade)FDA Link 03/2020 - 03/2006
7	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2016 - 03/2006
5	CytokinesIBA 11/2014 - 03/2006
4	Biomarkers (Surrogate Marker)IBA 10/2020 - 08/2007
4	AntioxidantsIBA 01/2020 - 06/2002
4	Methotrexate (Mexate)FDA LinkGeneric 01/2020 - 07/2004
4	EnzymesIBA 01/2019 - 06/2002
4	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2018 - 06/2006
3	SteroidsIBA 01/2020 - 09/2004
3	AntigensIBA 01/2020 - 08/2005
3	Adalimumab (Humira)FDA Link 01/2016 - 06/2014
3	Prednisone (Sone)FDA LinkGeneric 09/2014 - 09/2009
3	Proteins (Proteins, Gene)FDA Link 06/2011 - 08/2007
3	HLA-DQB1 antigen (HLA DQB1)IBA 04/2011 - 06/2005
3	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 09/2010 - 01/2008
3	C-Reactive ProteinIBA 05/2008 - 09/2003
3	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 08/2007 - 09/2003
2	Cytochrome P-450 CYP2C9IBA 03/2019 - 02/2010
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2019 - 03/2009
2	Vitamin K FDA Link 01/2019 - 01/2018
2	Surface-Active Agents (Surfactants)IBA 03/2016 - 07/2015
2	Biological ProductsIBA 01/2015 - 05/2004
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 05/2014 - 03/2003
2	QuercetinIBA 08/2011 - 03/2009
2	3-Iodobenzylguanidine (Iobenguane)IBA 01/2008 - 03/2005
2	Interleukin-2 Receptors (IL 2 Receptor)IBA 08/2007 - 09/2003
2	Serum Amyloid A Protein (Serum Amyloid A)IBA 06/2004 - 09/2003
2	Peroxidase (Myeloperoxidase)IBA 05/2004 - 08/2003
1	Simvastatin (Zocor)FDA LinkGeneric 11/2021
1	Cytochrome P-450 CYP3AIBA 11/2021
1	Pyrethrins (Pyrethroids)FDA Link 01/2021
1	Rituximab (Mabthera)FDA Link 01/2020
1	Complement System Proteins (Complement)IBA 01/2020
1	Pepsin A (Pepsin)IBA 01/2020
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2020
1	Silicon Dioxide (Silica)FDA LinkGeneric 01/2019
1	DesmosineIBA 01/2018
1	ElastinIBA 01/2018
1	Pancreatic Elastase (Elastase)IBA 01/2018
1	Volatile Organic CompoundsIBA 11/2017
1	Lipoproteins (Lipoprotein)IBA 03/2016
1	Phospholipids (Phosphatides)FDA LinkGeneric 03/2016
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 12/2015
1	AutoantibodiesIBA 12/2015
1	Glucose (Dextrose)FDA LinkGeneric 08/2015
1	Glyphosate (Roundup)IBA 07/2015
1	cibinetideIBA 01/2015
1	Erythropoietin FDA Link 01/2015
1	Immunoglobulins (Immunoglobulin)IBA 01/2015
1	golimumab FDA Link 11/2014
1	Ustekinumab (CNTO 1275)FDA Link 11/2014
1	Interleukin-23 (Interleukin 23)IBA 11/2014
1	InterleukinsIBA 11/2014
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 09/2014
1	Leflunomide (Arava)FDA LinkGeneric 09/2014
1	Azathioprine (Imuran)FDA LinkGeneric 09/2014
1	Cytotoxins (Cytolysins)IBA 09/2014
1	Tumor Necrosis Factor InhibitorsIBA 06/2014
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 04/2014

Therapy/Procedure

20	Therapeutics 01/2022 - 03/2004
2	Aftercare (After-Treatment) 03/2006 - 06/2004
1	Polypharmacy 01/2022
1	Fitness Trackers 08/2020
1	Biological Therapy 03/2020
1	Intravenous Administration 01/2015
1	Duration of Therapy 07/2014